US 12226373
Treatment of fragile X syndrome with cannabidiol
granted A61KA61K31/658A61K36/185
Quick answer
US patent 12226373 (Treatment of fragile X syndrome with cannabidiol) held by Harmony Biosciences Management, Inc. expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Harmony Biosciences Management, Inc.
- Grant date
- Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/658, A61K36/185, A61K9/0014, A61K9/06